• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非药物干预治疗甲基苯丙胺使用障碍:系统综述。

Non-pharmacological interventions for methamphetamine use disorder: a systematic review.

机构信息

Research Division, Institute of Mental Health, 10 Buangkok View, Singapore.

Research Division, Institute of Mental Health, 10 Buangkok View, Singapore.

出版信息

Drug Alcohol Depend. 2020 Jul 1;212:108060. doi: 10.1016/j.drugalcdep.2020.108060. Epub 2020 May 13.

DOI:10.1016/j.drugalcdep.2020.108060
PMID:32445927
Abstract

BACKGROUND

Methamphetamine (METH) use is on the rise globally, with the number of treatment seekers increasing exponentially across the globe. Evidence-based therapies are needed to meet rising treatment needs. This systematic review intends to appraise the existing evidence to identify effective non-pharmaceutical approaches for the treatment of METH use disorder.

METHODS

Five electronic bibliographic databases-Ovid (Medline), Embase, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Web of Science and PsycINFO- were searched to identify relevant studies that were published between January 1995 to February 2020. Studies were selected and assessed by two independent reviewers. A systematic review of data from both randomised control trials (RCT) and non-RCTs was conducted to appraise the evidence.

RESULTS

A total of 44 studies were included in the review. Behavioural interventions, i.e. cognitive behavioural therapy (CBT), contingency management (CM), exercise, residential rehabilitation based therapies, repetitive transcranial magnetic stimulation (rTMS), and matrix model demonstrated treatment efficacy in promoting abstinence, reducing methamphetamine use or craving in the participants. While CM interventions showed the strongest evidence favouring the outcomes assessed, tailored CBT alone or with CM was also effective in the target population.

CONCLUSIONS

Behavioural interventions should be considered as the first line of treatment for methamphetamine use disorder. Future studies should address the longevity of the effects, and limitations due to smaller sample sizes and high dropout rates to enable better assessment of evidence.

摘要

背景

冰毒(METH)的使用在全球范围内呈上升趋势,寻求治疗的人数在全球呈指数级增长。需要循证治疗来满足不断增长的治疗需求。本系统评价旨在评估现有证据,以确定治疗冰毒使用障碍的有效非药物方法。

方法

检索了五个电子文献数据库 - Ovid(医学文献在线)、Embase、护理学及相关健康专业文献累积索引(CINAHL)、Web of Science 和 PsycINFO-,以确定发表于 1995 年 1 月至 2020 年 2 月之间的相关研究。研究由两名独立的评审员进行选择和评估。对随机对照试验(RCT)和非 RCT 的数据进行系统评价,以评估证据。

结果

共纳入 44 项研究。行为干预,即认知行为疗法(CBT)、条件管理(CM)、运动、基于住院康复的治疗、重复经颅磁刺激(rTMS)和矩阵模型,在促进参与者戒除、减少冰毒使用或渴望方面显示出治疗效果。虽然 CM 干预显示出支持评估结果的最强证据,但针对特定人群的量身定制的 CBT 单独或与 CM 联合使用也有效。

结论

行为干预应被视为治疗冰毒使用障碍的一线治疗方法。未来的研究应解决效果的持久性问题,并解决由于样本量较小和高辍学率导致的局限性,以便更好地评估证据。

相似文献

1
Non-pharmacological interventions for methamphetamine use disorder: a systematic review.非药物干预治疗甲基苯丙胺使用障碍:系统综述。
Drug Alcohol Depend. 2020 Jul 1;212:108060. doi: 10.1016/j.drugalcdep.2020.108060. Epub 2020 May 13.
2
A systematic review of cognitive and behavioural therapies for methamphetamine dependence.对甲基苯丙胺依赖的认知和行为疗法的系统评价。
Drug Alcohol Rev. 2008 May;27(3):309-17. doi: 10.1080/09595230801919494.
3
Contingency management for the treatment of methamphetamine use disorder: A systematic review.应对甲基苯丙胺使用障碍的权变管理:系统评价。
Drug Alcohol Depend. 2020 Nov 1;216:108307. doi: 10.1016/j.drugalcdep.2020.108307. Epub 2020 Sep 21.
4
Effect of exercise versus cognitive behavioural therapy or no intervention on anxiety, depression, fitness and quality of life in adults with previous methamphetamine dependency: a systematic review.运动与认知行为疗法或不干预对有既往甲基苯丙胺依赖的成年人的焦虑、抑郁、健康和生活质量的影响:系统评价。
Addict Sci Clin Pract. 2018 Jan 16;13(1):4. doi: 10.1186/s13722-018-0106-4.
5
Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern.苯丙胺类兴奋剂滥用/使用障碍的治疗:一个最近健康关注点的系统评价。
Daru. 2019 Dec;27(2):743-753. doi: 10.1007/s40199-019-00282-3. Epub 2019 Jun 21.
6
Media-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disorders in adults.针对成人焦虑症的媒体传播认知行为疗法和行为疗法(自助)
Cochrane Database Syst Rev. 2013 Sep 9;2013(9):CD005330. doi: 10.1002/14651858.CD005330.pub4.
7
Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.复杂创伤性事件后创伤后应激障碍及共患精神健康问题的心理和药理学干预措施:系统评价和成分网络荟萃分析。
PLoS Med. 2020 Aug 19;17(8):e1003262. doi: 10.1371/journal.pmed.1003262. eCollection 2020 Aug.
8
Feasibility and acceptability of approach bias modification during methamphetamine withdrawal and related methamphetamine use outcomes.阿片类药物戒断期间和相关阿片类药物使用结果中趋近偏差修正的可行性和可接受性。
J Subst Abuse Treat. 2019 Nov;106:12-18. doi: 10.1016/j.jsat.2019.07.008. Epub 2019 Jul 19.
9
Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report.成人大麻戒断的心理和社会心理干预:系统评价简短报告
Health Technol Assess. 2015 Jul;19(56):1-130. doi: 10.3310/hta19560.
10
Development of an evidence-based, gay-specific cognitive behavioral therapy intervention for methamphetamine-abusing gay and bisexual men.为滥用甲基苯丙胺的男同性恋者和双性恋男性开发一种基于证据的、针对同性恋者的认知行为疗法干预措施。
Addict Behav. 2014 Aug;39(8):1286-91. doi: 10.1016/j.addbeh.2011.11.029. Epub 2011 Nov 26.

引用本文的文献

1
Tū Whakaruruhau: the evaluation of treatment outcomes for methamphetamine dependence in Aotearoa, New Zealand - study protocol for a prospective longitudinal cohort study and longitudinal qualitative study.图·瓦卡罗鲁豪:新西兰奥塔哥地区甲基苯丙胺依赖治疗效果评估——一项前瞻性纵向队列研究和纵向定性研究的研究方案
BMC Health Serv Res. 2025 Aug 25;25(1):1131. doi: 10.1186/s12913-025-13233-3.
2
Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks.氯胺酮辅助康复(KARE):一项针对有甲基苯丙胺使用障碍和感染艾滋病毒风险的公共保险患者的氯胺酮辅助心理治疗开放标签试点试验方案。
BMJ Open. 2025 Aug 24;15(8):e100775. doi: 10.1136/bmjopen-2025-100775.
3
Factors associated with 30-day drug-related emergency department re-attendance among methamphetamine users: a territory-wide retrospective study in Hong Kong.甲基苯丙胺使用者30天内与药物相关的急诊科再就诊相关因素:香港一项全地区回顾性研究
BMC Emerg Med. 2025 Aug 22;25(1):166. doi: 10.1186/s12873-025-01325-6.
4
The Effects of Active Methamphetamine Use Disorder and Regular Sports Activities on Brain Volume in Adolescents.青少年中活跃的甲基苯丙胺使用障碍和定期体育活动对脑容量的影响。
J Clin Med. 2025 Jul 23;14(15):5212. doi: 10.3390/jcm14155212.
5
Implementation of contingency management with women engaging in polysubstance use.对使用多种物质的女性实施应急管理。
Addict Sci Clin Pract. 2025 Aug 8;20(1):63. doi: 10.1186/s13722-025-00590-x.
6
The peers expanding engagement in stimulant harm reduction with contingency management study: a protocol paper.同伴通过应急管理研究扩大减少兴奋剂危害参与度的研究:一篇方案论文。
Addict Sci Clin Pract. 2025 Jun 10;20(1):48. doi: 10.1186/s13722-025-00577-8.
7
Commentary on Ezard et al.: Agonist-based medications for stimulant use disorder-Distinguishing their true colours.对埃扎德等人的评论:用于兴奋剂使用障碍的基于激动剂的药物——辨别它们的真面目。
Addiction. 2025 Jul;120(7):1363-1365. doi: 10.1111/add.70091. Epub 2025 May 8.
8
Case Report: Unusual oral cavity changes associated with methamphetamine abuse.病例报告:与甲基苯丙胺滥用相关的异常口腔变化。
Front Public Health. 2025 Apr 2;13:1473584. doi: 10.3389/fpubh.2025.1473584. eCollection 2025.
9
Genes, Cognition, and Their Interplay in Methamphetamine Use Disorder.基因、认知及其在甲基苯丙胺使用障碍中的相互作用
Biomolecules. 2025 Feb 19;15(2):306. doi: 10.3390/biom15020306.
10
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder.移动健康激励依从性加患者导航(MIAPP):一项试点随机对照试验的方案,旨在改善甲基苯丙胺使用和阿片类药物使用障碍住院患者丁丙诺啡的联系和维持治疗。
Addict Sci Clin Pract. 2025 Jan 29;20(1):6. doi: 10.1186/s13722-025-00538-1.